Literature DB >> 3469716

Semiology, nosology and criteria for tic disorders.

E Shapiro, A K Shapiro.   

Abstract

Precise description of the signs, symptoms, classification and criteria for Tic Disorder and Gilles de la Tourette Syndrome (GTS) is important to reduce heterogeneity in studies and to develop hypotheses about the pathophysiology of these disorders. Previous diagnostic categories and criteria for Tic Disorders and GTS in DSM-III and ICD-9 were derived from our study of 114 consecutive patients, questionnaire responses by 31 patients and data on 76 patients from 8 published reports. During the past 20 years we have evaluated 1490 patients for movement disorders, of whom 1210 had GTS and 137 had another tic disorder. Analysis of these data and review of the literature serve as the basis for proposed revision of the signs, symptoms, nosology and criteria for Tic Disorders and GTS.

Entities:  

Mesh:

Year:  1986        PMID: 3469716

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  4 in total

1.  Contingent negative variation in adults with Gilles de la Tourette syndrome.

Authors:  T C van Woerkom; C Fortgens; B J van de Wetering; C M Martens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

2.  Bridging neuroscience and clinical psychology: cognitive behavioral and psychophysiological models in the evaluation and treatment of Gilles de la Tourette syndrome.

Authors:  Marc E Lavoie; Julie Leclerc; Kieron P O'Connor
Journal:  Neuropsychiatry (London)       Date:  2013-02-01

3.  Brain-behavior relations during motor processing in chronic tic and habit disorder.

Authors:  Kieron P O'Connor; Marc E Lavoie; Manon Robert; Emmanuel Stip; François Borgeat
Journal:  Cogn Behav Neurol       Date:  2005-06       Impact factor: 1.600

Review 4.  Provisional Tic Disorder: What to tell parents when their child first starts ticcing.

Authors:  Kevin J Black; Elizabeth Rose Black; Deanna J Greene; Bradley L Schlaggar
Journal:  F1000Res       Date:  2016-04-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.